hepatocellular carcinoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Hepatocellular carcinoma was diagnosed before surgery; 2. No extrahepatic metastasis by preoperative imaging examination; 3. Aged 18 to 75 years old; 4. HCC patients with BCLC stage 0 or stage A; 5. Liver function of Child-Pugh A; 6. Patients who agree to sign the informed consent; 7. Laparoscopic major hepatectomy(more than three hepatic segments).;Inclusion criteria: 1. Hepatocellular carcinoma was diagnosed before surgery; 2. No extrahepatic metastasis by preoperative imaging examination; 3. Aged 18 to 75 years old; 4. HCC patients with BCLC stage 0 or stage A; 5. Liver function of Child-Pugh A; 6. Patients who agree to sign the informed consent; 7. Laparoscopic major hepatectomy(more than three hepatic segments).;Inclusion criteria: 1. Hepatocellular carcinoma was diagnosed before surgery; 2. No extrahepatic metastasis by preoperative imaging examination; 3. Aged 18 to 75 years old; 4. HCC patients with BCLC stage 0 or stage A; 5. Liver function of Child-Pugh A; 6. Patients who agree to sign the informed consent; 7. Laparoscopic major hepatectomy(more than three hepatic segments).;Inclusion criteria: 1. Hepatocellular carcinoma was diagnosed before surgery; 2. No extrahepatic metastasis by preoperative imaging examination; 3. Aged 18 to 75 years old; 4. HCC patients with BCLC stage 0 or stage A; 5. Liver function of Child-Pugh A; 6. Patients who agree to sign the informed consent; 7. Laparoscopic major hepatectomy(more than three hepatic segments).;Inclusion criteria: 1. Hepatocellular carcinoma was diagnosed before surgery; 2. No extrahepatic metastasis by preoperative imaging examination; 3. Aged 18 to 75 years old; 4. HCC patients with BCLC stage 0 or stage A; 5. Liver function of Child-Pugh A; 6. Patients who agree to sign the informed consent; 7. Laparoscopic major hepatectomy(more than three hepatic segments).
Exclusion criteria
Exclusion criteria: (1) Multiple histories of upper abdominal surgery or recurrent hepatocellular carcinoma; (2) Other organs except for gall bladder are involved during surgery; (3) Patients who accompany with severe organic diseases of heart, lung, kidney, et al.;Exclusion criteria: (1) Multiple histories of upper abdominal surgery or recurrent hepatocellular carcinoma; (2) Other organs except for gall bladder are involved during surgery; (3) Patients who accompany with severe organic diseases of heart, lung, kidney, et al.;Exclusion criteria: (1) Multiple histories of upper abdominal surgery or recurrent hepatocellular carcinoma; (2) Other organs except for gall bladder are involved during surgery; (3) Patients who accompany with severe organic diseases of heart, lung, kidney, et al.;Exclusion criteria: (1) Multiple histories of upper abdominal surgery or recurrent hepatocellular carcinoma; (2) Other organs except for gall bladder are involved during surgery; (3) Patients who accompany with severe organic diseases of heart, lung, kidney, et al.;Exclusion criteria: (1) Multiple histories of upper abdominal surgery or recurrent hepatocellular carcinoma; (2) Other organs except for gall bladder are involved during surgery; (3) Patients who accompany with severe organic diseases of heart, lung, kidney, et al.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1,3,5 year overall survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| perioperative complications;operation time;blood loss;hospital stay; | — |
Countries
China
Contacts
West China Hospital, Sichuan University;West China Hospital, Sichuan University;West China Hospital, Sichuan University;West China Hospital, Sichuan University;West China Hospital, Sichuan University